Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic?
Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

Is Accenture (ACN) a Buy as Wall Street Analysts Look Optimistic?
Is Accenture (ACN) a Buy as Wall Street Analysts Look Optimistic?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

Solventum (SOLV) Recently Broke Out Above the 200-Day Moving Average
Solventum (SOLV) Recently Broke Out Above the 200-Day Moving Average

Solventum (SOLV) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, SOLV broke through the 200-day moving average, which suggests a

Compared to Estimates, Under Armour (UAA) Q4 Earnings: A Look at Key Metrics
Compared to Estimates, Under Armour (UAA) Q4 Earnings: A Look at Key Metrics

For the quarter ended March 2026, Under Armour (UAA) reported revenue of $1.17 billion, down 0.8% over the same period last year. EPS came in at -$0.03, compared to -$0.08 in the year-ago quarter.

Earnings Growth & Price Strength Make Block (XYZ) a Stock to Watch
Earnings Growth & Price Strength Make Block (XYZ) a Stock to Watch

Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.

One of our most popular

Is DXP Enterprises (DXPE) a Buy as Wall Street Analysts Look Optimistic?
Is DXP Enterprises (DXPE) a Buy as Wall Street Analysts Look Optimistic?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

Aramark (ARMK) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Aramark (ARMK) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

For the quarter ended March 2026, Aramark (ARMK) reported revenue of $4.91 billion, up 14.7% over the same period last year. EPS came in at $0.49, compared to $0.34 in the year-ago quarter.

The

Sleep Number (SNBR) Reports Q1 Loss, Beats Revenue Estimates
Sleep Number (SNBR) Reports Q1 Loss, Beats Revenue Estimates

Sleep Number (SNBR) came out with a quarterly loss of $2.19 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to a loss of $0.38 per share a year ago. These figures are

Why Micron (MU) is a Top Stock for the Long-Term
Why Micron (MU) is a Top Stock for the Long-Term

Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.

The Zacks Premium

QBTS Q1 Earnings Top Estimates, Revenues Miss, Stock Up
QBTS Q1 Earnings Top Estimates, Revenues Miss, Stock Up

D-Wave Quantum Inc. QBTS posted a first-quarter 2026 loss of 5 cents per share, narrower than the Zacks Consensus Estimate of a loss of 8 cents. The reported figure widened from a loss of 2 cents in

Company News for May 12, 2026Photo, wide shot, wide-angle lens,  Gold mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/94faf2bd-99c1-4ea6-b55d-fdcab23c3865.png
Company News for May 12, 2026
  • Barrick Mining Corporation’s B shares jumped 9% after reporting first-quarter 2026 adjusted earnings of 98 cents per share, beating the Zacks Consensus Estimate of 74 cents.
  • Shares of Kodiak Gas
Stock Market News for May 12, 2026Photo, wide shot, wide-angle lens,  Janitorial service, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/4d4e885c-79e9-4b8f-bd91-e9721cd7c2e9.png
Stock Market News for May 12, 2026

Wall Street closed slightly higher on Monday, driven by energy and industrial stocks. Investors continued buying technology and AI-linked stocks even as inflation-related concerns remained regarding

Lincoln Educational Services Corporation (LINC) Hit a 52 Week High, Can the Run Continue?
Lincoln Educational Services Corporation (LINC) Hit a 52 Week High, Can the Run Continue?

Have you been paying attention to shares of Lincoln Educational Services Corporation (LINC)? Shares have been on the move with the stock up 24.1% over the past month. The stock hit a new 52-week

Why SkinHealth Systems Inc. (SKIN) International Revenue Trends Deserve Your Attention
Why SkinHealth Systems Inc. (SKIN) International Revenue Trends Deserve Your Attention

Have you evaluated the performance of SkinHealth Systems Inc.'s (SKIN) international operations for the quarter ending March 2026? Given the extensive global presence of this company, analyzing the

Don't Overlook M/A-Com (MTSI) International Revenue Trends While Assessing the Stock
Don't Overlook M/A-Com (MTSI) International Revenue Trends While Assessing the Stock

Have you looked into how M/A-Com (MTSI) performed internationally during the quarter ending March 2026? Considering the widespread global presence of this chipmaker, examining the trends in

Monster Beverage (MNST) International Revenue Performance ExploredPhoto, wide shot, wide-angle lens,  Restaurant, sunset photo at golden hour, photo by Thomas Heaton: https://img.theapi.app/temp/57273392-070f-46de-9297-125616327242.png
Monster Beverage (MNST) International Revenue Performance Explored

Have you evaluated the performance of Monster Beverage's (MNST) international operations for the quarter ending March 2026? Given the extensive global presence of this energy drink maker, analyzing

Curious about Canadian Solar (CSIQ) Q1 Performance? Explore Wall Street Estimates for Key Metrics
Curious about Canadian Solar (CSIQ) Q1 Performance? Explore Wall Street Estimates for Key Metrics

Analysts on Wall Street project that Canadian Solar (CSIQ) will announce quarterly loss of -$1.08 per share in its forthcoming report, representing a decline of 0.9% year over year. Revenues are

OrganiGram (OGI) Reports Q2 Loss, Misses Revenue Estimates
OrganiGram (OGI) Reports Q2 Loss, Misses Revenue Estimates

OrganiGram (OGI) came out with a quarterly loss of $0.01 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.05 per share a year ago. These figures are adjusted for

3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income

Believe it or not, seniors fear running out of cash more than they fear dying.

And unfortunately, even retirees who have built a nest egg have good reason to be concerned-with the traditional

Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks

Here's a revealing data point: older Americans are scared more of outliving wealth than of death itself.

Also, retirees who have constructed a nest egg have valid justifications to be concerned

Fastly's Q1 Revenues Rise 20%: Can Growth Stay Near Record Highs?Photo, wide shot, wide-angle lens,  Telecom equipment supplier, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.theapi.app/temp/3967c11c-b755-4d39-87d0-acc853384c80.png
Fastly's Q1 Revenues Rise 20%: Can Growth Stay Near Record Highs?

Fastly, Inc. FSLY entered 2026 with strong momentum, as first-quarter revenues increased 20% year over year to a record $173 million. Rising demand across edge cloud, security and compute services

Celsius Says Energy Drink Demand Still Strong as Shelf Reset Weighs on GrowthPhoto, wide shot, wide-angle lens,  Brewery, Midday, harsh overhead sunlight, directional sunlightt, photo by Peter Lik: https://img.theapi.app/temp/0cebecb6-c4f6-4c6e-b73e-f375daba8100.png
Celsius Says Energy Drink Demand Still Strong as Shelf Reset Weighs on Growth

Celsius (NASDAQ:CELH) executives said the energy drink category remains stronger than expected, while the company is working through a temporary timing gap

Pangaea Logistics Solutions Q1 Earnings Call HighlightsPhoto, wide shot, wide-angle lens, soft focus,  Networking equipment supplier, sunset photo at golden hour, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-LvyAFCAMshu3rGBke5G5gxuI.png?st=2023-05-10T15%3A37%3A29Z&se=2023-05-10T17%3A37%3A29Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-10T02%3A36%3A27Z&ske=2023-05-11T02%3A36%3A27Z&sks=b&skv=2021-08-06&sig=nXxCmLby4SxAAd/YtNVxZStdXrs9BCydapQDQaR/oac%3D
Pangaea Logistics Solutions Q1 Earnings Call Highlights

Pangaea Logistics Solutions (NASDAQ:PANL) reported a stronger start to 2026, with management pointing to higher shipping activity, firmer dry bulk market conditions and continued benefits from its

Organigram Global Q2 Earnings Call Highlights
Organigram Global Q2 Earnings Call Highlights

Organigram Global (NASDAQ:OGI) reported a weaker second quarter for fiscal 2026, with management attributing the decline to operational issues

Legend Biotech Q1 Earnings Call HighlightsPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
Legend Biotech Q1 Earnings Call Highlights

Legend Biotech (NASDAQ:LEGN) reported sharply higher first-quarter 2026 sales for CARVYKTI, its CAR T therapy for multiple myeloma, as management said demand